Rev Genomics is Agricultural Chemicals in United States that focus on trait mapping technologies business. Founded in 2015. They cover business area such as developer, novel plant phenotype, plant medicine, improved crop production, advanced tissue culture process, cultivar, innovative genomic and bioinformatics analysis, molecular marker, quantitative trait mapping technology, enable breeder, cultivator, seed bank, valuable biochemical.
2015
( 9 years old in 2024 )
Trait Mapping Technologies
-
4678 Dolores Avenue
Oakland, CA 94602
United States
Private
developernovel plant phenotypeplant medicineimproved crop productionadvanced tissue culture processcultivarinnovative genomic and bioinformatics analysismolecular markerquantitative trait mapping technologyenable breedercultivatorseed bankvaluable biochemical
* We use standard office opening hours in near Rev Genomics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Rev Genomics is Agricultural Chemicals business from United States that founded in 2015 (9 years old in 2024), Rev Genomics business is focusing on Trait Mapping Technologies.
Rev Genomics headquarter office and corporate office address is located in 4678 Dolores Avenue Oakland, CA 94602 United States.
Rev Genomics was founded in United States.
In 2024, Rev Genomics is currently focus on trait mapping technologies sector.
Above is snippet of Google Trends for "trait mapping technologies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Rev Genomics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
